Todd C. Brady
2017
In 2017, Todd C. Brady earned a total compensation of $2.4M as President and Chief Executive Officer at Aldeyra Therapeutics, a 40% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $239,800 |
|---|---|
| Option Awards | $955,632 |
| Salary | $473,000 |
| Stock Awards | $697,711 |
| Total | $2,366,143 |
Brady received $955.6K in option awards, accounting for 40% of the total pay in 2017.
Brady also received $239.8K in non-equity incentive plan, $473K in salary and $697.7K in stock awards.
Rankings
In 2017, Todd C. Brady's compensation ranked 4,696th out of 14,666 executives tracked by ExecPay. In other words, Brady earned more than 68.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,696 out of 14,666 | 68th |
Division Manufacturing | 1,655 out of 5,772 | 71st |
Major group Chemicals And Allied Products | 481 out of 2,075 | 77th |
Industry group Drugs | 371 out of 1,731 | 79th |
Industry Pharmaceutical Preparations | 293 out of 1,333 | 78th |
Source: SEC filing on April 25, 2018.
Brady's colleagues
We found two more compensation records of executives who worked with Todd C. Brady at Aldeyra Therapeutics in 2017.
News
Aldeyra Therapeutics CEO Todd Brady's 2023 pay jumps 29% to $3.7M
April 22, 2024
Aldeyra Therapeutics CEO Todd Brady's 2022 pay slips 17% to $2.9M
May 23, 2023
Aldeyra Therapeutics CEO Todd Brady's 2021 pay jumps 43% to $3.5M
April 25, 2022
Aldeyra Therapeutics CEO Todd Brady's 2019 pay jumps 44% to $4.1M
April 27, 2020
Aldeyra Therapeutics CEO Todd Brady's 2018 pay jumps 21% to $2.9M
April 22, 2019